[{"address1": "3710 \u2013 33rd Street NW", "city": "Calgary", "state": "AB", "zip": "T2L 2M1", "country": "Canada", "phone": "403 455 7727", "website": "https://www.xortx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Allen Warren Davidoff Ph.D.", "age": 64, "title": "Founder, CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 391655, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Scott Bumby D.V.M., M.B.A.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 6515, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Haworth M.D., MRCP", "age": 74, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2024, "totalPay": 110445, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stacy  Evans M.B.A., M.D.", "age": 50, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 157500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nick  Rigopoulos", "title": "Director of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Sans M.B.A., Ph.D.", "age": 54, "title": "Director of Corporate Development", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  MacDonald Ph.D.", "age": 61, "title": "Consultant of Clinical Operations", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Charlotte  May", "title": "Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.7182, "open": 0.71, "dayLow": 0.648, "dayHigh": 0.735, "regularMarketPreviousClose": 0.7182, "regularMarketOpen": 0.71, "regularMarketDayLow": 0.648, "regularMarketDayHigh": 0.735, "payoutRatio": 0.0, "beta": -0.18, "forwardPE": -0.39526945, "volume": 413948, "regularMarketVolume": 413948, "averageVolume": 1918476, "averageVolume10days": 11923750, "averageDailyVolume10Day": 11923750, "bid": 0.6399, "ask": 0.6791, "bidSize": 4, "askSize": 4, "marketCap": 4593536, "fiftyTwoWeekLow": 0.629, "fiftyTwoWeekHigh": 1.79, "allTimeHigh": 495.72, "allTimeLow": 0.629, "fiftyDayAverage": 0.82706, "twoHundredDayAverage": 0.908325, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2457581, "profitMargins": 0.0, "floatShares": 5075814, "sharesOutstanding": 6958849, "sharesShort": 7330, "sharesShortPriorMonth": 19700, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0014, "heldPercentInsiders": 0.025020001, "heldPercentInstitutions": 0.046430003, "shortRatio": 0.14, "shortPercentOfFloat": 0.0015, "impliedSharesOutstanding": 7686117, "bookValue": 0.536, "priceToBook": 1.2315298, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -1880849, "trailingEps": -0.46, "forwardEps": -1.67, "lastSplitFactor": "1:9", "lastSplitDate": 1699920000, "enterpriseToEbitda": -0.963, "52WeekChange": -0.5755627, "SandP52WeekChange": 0.16625166, "quoteType": "EQUITY", "currentPrice": 0.6601, "targetHighPrice": 13.762058, "targetLowPrice": 13.762058, "targetMeanPrice": 13.762058, "targetMedianPrice": 13.762058, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 1063477, "totalCashPerShare": 0.204, "ebitda": -2552788, "totalDebt": 80473, "quickRatio": 1.51, "currentRatio": 1.777, "debtToEquity": 3.963, "returnOnAssets": -0.42154998, "returnOnEquity": -0.79440004, "freeCashflow": -2797770, "operatingCashflow": -3075508, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "XRTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketTime": 1761350390, "regularMarketTime": 1761336000, "exchange": "NCM", "messageBoardId": "finmb_259860883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "fiftyDayAverageChange": -0.16696, "fiftyDayAverageChangePercent": -0.2018717, "twoHundredDayAverageChange": -0.24822503, "twoHundredDayAverageChangePercent": -0.27327776, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-13", "cryptoTradeable": false, "corporateActions": [], "shortName": "XORTX Therapeutics Inc.", "longName": "XORTX Therapeutics Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1632403800000, "postMarketChangePercent": 0.136348, "postMarketPrice": 0.661, "postMarketChange": 0.00090003, "regularMarketChange": -0.0581, "regularMarketDayRange": "0.648 - 0.735", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1918476, "fiftyTwoWeekLowChange": 0.031099975, "fiftyTwoWeekLowChangePercent": 0.04944352, "fiftyTwoWeekRange": "0.629 - 1.79", "fiftyTwoWeekHighChange": -1.1299, "fiftyTwoWeekHighChangePercent": -0.63122904, "fiftyTwoWeekChangePercent": -57.55627, "regularMarketChangePercent": -8.08967, "regularMarketPrice": 0.6601, "earningsTimestamp": 1755057600, "earningsTimestampStart": 1763037000, "earningsTimestampEnd": 1763037000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.46, "epsForward": -1.67, "epsCurrentYear": -1.307, "priceEpsCurrentYear": -0.5050497, "displayName": "XORTX Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-10-25"}]